Check 35,000+ stocks against 26 valuation models and 37 quality factors

Taiwan Hopax Chemsistry MFG Co Ltd (6509) fair value: what the stock is really worth

As of Sep 24, 2026: fair value of Taiwan Hopax Chemsistry MFG Co Ltd TWD 48.86, price TWD 47.55, upside +2.8%, quality 65 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

Fair value above price? Yes
Good quality? Yes
Add to watchlist

Basic Materials · TW · ISIN TW0006509003

TH Broad data Sep 24, 2026

Taiwan Hopax Chemsistry MFG Co Ltd

6509 · TWO

NeutralThe stock looks roughly fairly valued with average quality.

·Fair value 48.86 TWD · Fairly valued (+3%)

✓Quality 65/100

!Weak Growth (revenue 5y +6.3 %/yr)

✓Solidly profitable · 12.9% net margin (TTM)

✓Low debt · generates free cash flow

·2.94% dividend yield

✓Ranks above peers (13/14)

!Moderate moat 62/100

!Weak on future: 27 out of 100

26 models, one by oneBear 36.64 TWD to bull 61.07 TWD Growth analysisrevenue history, year by year Quality 65/100 in detail37 factors, each one shown Compared with its peersrank on every measure, side by side

Watch Taiwan Hopax Chemsistry MFG Co Ltd for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

60‑month range 25.06 TWD – 75.05 TWD · fair‑value band 36.64 TWD – 61.07 TWD · the 47.55 TWD price screens below the 48.86 TWD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.

Follow Taiwan Hopax Chemsistry MFG Co in your weekly email

Every Wednesday you see whether Taiwan Hopax Chemsistry MFG Co is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Taiwan Hopax Chemicals Manufacturing Co., Ltd. manufactures, processes, and sells chemical raw materials for pharmaceutical, industrial, paper making, and office stationery industries in Taiwan, rest of Asia, Europe, America, and internationally. It operates through Specialty Chemicals, Fine Chemicals, Office Stationery, and Other segments. The company offers paper making chemicals, such as hollow resins, dispersant, lubricants, anionic (cationic) surface sizing agent, ultra-fine dispersant for wet-grinding calcium carbonate, medium alkaline sizing agent, anion neutralizing agent, cohesion enhancer, retention and drainage aid, and titanium dioxide dispersant; and chemical materials for water treatment, including polymers, COD removal agent, fly ash curing agent, metal capturing agent, polyaluminum chloride, sedimentation control agent, geotechnical stabilizer, chelating agent, and dispersant. It also provides NCR chemicals comprising NTR, color developers, microcapsules, spacer, wall materials, and emulsifiers; fine chemicals, including biological cleaning agents, biological buffers, waterborne polyurethane, sulfonate chain modifiers, additives for electroplating and lithium-ion batteries, and aldehyde removal additives; office supplies, such as repositionable self-adhesive products (Stick'N), self-adhesive markers and tapes, sticky products for education purposes, and customized sticky products; and de-formaldehyde removal products, anti-bacterial, home cleaning, pet care, and NBC mesh products. In addition, the company provides office stationery, medical supplies, and biotechnology, as well as engages in investment activities. The company was formerly known as Taiwan Hopax Chemical Industrial Co., Ltd. and changed its name to Taiwan Hopax Chemicals Manufacturing Co., Ltd. in October 1996. Taiwan Hopax Chemicals Manufacturing Co., Ltd. was incorporated in 1975 and is headquartered in Kaohsiung, Taiwan.

Stock analysis

Taiwan Hopax Chemsistry MFG Co Ltd (6509) currently trades at 47.55 TWD, while our model-based Fair Value estimate is 48.86 TWD, implying the stock looks roughly 2.7% fairly valued today.

Valuation

Bull case: the DCF Models group reads highest at a median of 50.94 TWD per share, and 11 of the 25 models we run sit above the 47.55 TWD price.

Bear case: the Dividend Discount group reads lowest at 12.37 TWD, and 14 of the 25 models stay below the price. Evidence for this calculation is high.

Scenario range: 36.64 TWD (bear) to 61.07 TWD (bull), the price of 47.55 TWD sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 65/100 (solid quality), in the Basic Materials sector.

Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.

Taiwan Hopax Chemsistry MFG Co Ltd reported revenue of 4.9B TWD in FY2025 versus 4.7B TWD in FY2021, a compound +0.8%/yr. Reported net income was 567M TWD in FY2025, compounding +7.3%/yr from FY2021.

Key figures

Market cap 9.3B TWD (≈ $294M) · P/E ratio 17.4 · P/S ratio 2.03 · EPS (TTM) 2.73 TWD · Dividend yield 2.9% · Net margin 11.6% · Return on equity 12.5% · Return on assets (EBIT) 9.9%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 51 out of 100 (low confidence).

What moves the price

The share trades about 17% below its 52-week high and 57% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Basic Materials peers we cover trades at −40% fair-value upside, at 3%, 6509 screens cheaper than that median.

Fair Value models

Bear 36.64 TWD Fair Value 48.86 TWD Bull 61.07 TWD

Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (0.9765 TWD per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.

Highest evidence

FCF DCF 41.00 TWD 50.94 TWD 62.42 TWD 82

Growth DCF 41.38 TWD 50.35 TWD 60.27 TWD 80

Owner Earnings 26.71 TWD 32.38 TWD 38.93 TWD 78

All 25 models by family

DCF Models

FCF DCF 41.00 TWD 50.94 TWD 62.42 TWD 82

Owner Earnings 26.71 TWD 32.38 TWD 38.93 TWD 78

5Y Revenue Exit 36.02 TWD 47.52 TWD 61.38 TWD 74

5Y EBITDA Exit 43.07 TWD 60.02 TWD 78.75 TWD 76

5Y P/E Exit 40.24 TWD 55.01 TWD 69.55 TWD 72

10Y Revenue Exit 37.45 TWD 47.12 TWD 58.60 TWD 68

10Y EBITDA Exit 41.77 TWD 54.33 TWD 69.39 TWD 70

10Y P/E Exit 40.26 TWD 51.44 TWD 63.68 TWD 65

Earnings-Based

Graham-Dodd 19.54 TWD 45.69 TWD 58.77 TWD 65

PEG = 1.0 7.81 TWD 11.15 TWD 14.50 TWD 57

EPV 33.59 TWD 36.69 TWD 39.21 TWD 74

Dividend Discount

Gordon GGM 9.15 TWD 13.48 TWD 17.34 TWD 69

DDM Multi-Stage 9.15 TWD 12.37 TWD 15.24 TWD 67

Multiples

P/E Multiple 36.64 TWD 48.86 TWD 61.07 TWD 63

P/S Multiple 27.79 TWD 37.05 TWD 46.32 TWD 58

P/B Multiple 36.64 TWD 48.86 TWD 61.07 TWD 55

EV/EBIT 51.29 TWD 65.81 TWD 80.33 TWD 66

EV/EBITDA 50.29 TWD 64.48 TWD 78.67 TWD 67

EV/Revenue 33.66 TWD 44.77 TWD 55.89 TWD 54

Asset-Based

NCAV (Graham) 13.29 TWD 17.81 TWD 26.58 TWD 54

Growth DCF

Growth DCF 41.38 TWD 50.35 TWD 60.27 TWD 80

Rev-Margin DCF 36.02 TWD 48.12 TWD 61.25 TWD 74

Economic Profit

Residual Income 21.54 TWD 23.35 TWD 26.53 TWD 76

ROIC Compounder 34.19 TWD 38.35 TWD 42.47 TWD 72

Growth Earnings

Growth-Adj P/E 28.14 TWD 40.20 TWD 52.26 TWD 67

Open the full fair value analysis →

Notify me when 6509 reaches fair value

Put 6509 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 65/100

Of which business quality 66 · Market factors (momentum, volatility) 64

Profitability 46

Margins and returns on capital today

Quality Growth 37

Are margins and returns improving?

Cashflow 78

Earnings quality: real cash, not paper profit

Fin. Strength 92

Balance sheet, leverage, solvency risk

Investment 56

Disciplined investing over empire-building

Low Volatility 75

Calm price path (market factor)

Momentum 53

Price trend over the last 3–12 months (market factor)

52W Momentum 69

Distance to the 52-week high (market factor)

Net Issuance 73

Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 40/100

Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.

Revenue growth 1 year

+2.8%

Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

−3.7%

Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+6.3%

Start year 2020 (pandemic). Over 10 years: +4.5% a year

Revenue growth 16 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+3.2%

’14

’15

’16

’17

’18

’19

’20

’21

’22

’23

’24

’25

What shareholders gained per year (last 5 years), in TWD ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in TWD: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.

+15.0%

Earnings growth per share plus dividend.

Earnings per share, growth per year+12.1%

Dividend (yield on the price)2.9%

Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.12% vs 19%, slowing

Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.11% → 17%

Start year 2020 (pandemic)

Growth Forecast

Price in line with expectations

The price assumes about as much growth as the company has delivered so far.

What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).

+4.4%

Yearly growth needed for the next five years to justify today's price.

What forecasts expect

n/a

No analyst forecast available.

After inflation (Taiwan: IMF forecast 1.6% a year to 2030, 1.5% from 2016 to 2025) that is about +2.8% a year for the price.

Watch 6509, get fair value alerts →

Compare Taiwan Hopax Chemsistry MFG Co Ltd with another stock

Price, fair value, quality and upside side by side.

First stock

Second stock

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 713 stocks

Beats the industry median on 13/14 measures

Overall it ranks above its industry peers.

Valuation

Quality Score 65 · Top 25%

Fair Value upside +3% · Above median

Profitability

Return on equity (TTM) 12% · Top 25%

Return on assets 7% · Top 25%

Net margin (TTM) 13% · Top 25%

Operating margin (TTM) 23% · Top 25%

Growth and dividend

Revenue growth 5% · Above median

Dividend yield (TTM) 2.9% · Above median

Balance sheet

Debt / equity 0.02× · Below median

Valuation Multiplesvs Specialty Chemicals median · lower = cheaper

P/E (TTM) 17.4× · Cheaper than median

P/B 1.78× · Cheaper than median

P/S (TTM) 1.89× · Pricier than median

P/FCF 0.4× · Cheaper than median

EV/EBITDA 6.4× · Cheapest 25%

Strength profile in five axes (Snowflake)

This stock

Sector peers

VALUE (fair-value potential)37 · sector 0

FUTURE (revenue growth)27 · sector 21

PAST (return on equity)50 · sector 23

HEALTH (low debt)99 · sector 95

DIVIDEND (yield)59 · sector 29

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate.

Stock	Price	Fair Value	vs Fair Value
Linde plc LIN	$469.72	$441.28	−6%
The Sherwin-Williams Company SHW	$326.46	$148.97	−54%
Ecolab Inc ECL	$276.72	$96.18	−65%
Air Products and Chemicals, Inc APD	$286.97	$122.14	−57%
Nan Ya Plastics Corporation 1303	238.00 TWD	235.25 TWD	−1%
Givaudan SA GIVN	CHF 3,406	CHF 1,523	−55%
Wanhua Chemical Group 600309	¥71.60	¥68.03	−5%
Asian Paints Limited ASIANPAINT	₹2,455	₹1,479	−40%
PPG Industries, Inc PPG	$107.20	$77.06	−28%
DSM-Firmenich AG DSFIR	CHF 91.50	CHF 29.27	−68%

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued High-Quality Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks Undervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark

Run the numbers yourself: free valuation calculators

DCF Calculator Graham Number Peter Lynch Formula DDM Calculator Fama-French Model Intrinsic Value

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Taiwan Hopax Chemsistry MFG Co Ltd · Fair Value
48.86 TWD +3%Fair Value
Calculator →

<a href="https://www.fairvalue-calculator.com/stock/6509" target="_blank" rel="nofollow noopener" style="display:inline-flex;align-items:center;gap:12px;box-sizing:border-box;font-family:system-ui,-apple-system,Segoe UI,Roboto,sans-serif;text-decoration:none;background:#0f1814;color:#eaf2ed;border:1px solid #2a3a30;border-radius:12px;padding:12px 16px;max-width:360px"><span style="line-height:1.35"><span style="font-size:12px;color:#9fb0a8">Taiwan Hopax Chemsistry MFG Co Ltd · Fair Value</span><br><b style="font-size:20px">48.86 TWD</b> <span style="color:var(--fvc-g-mitte);font-weight:700;font-size:14px">+3%</span></span><span style="font-size:11px;color:var(--fvc-g-mitte);font-weight:700;margin-left:auto;text-align:right;line-height:1.3">Fair&nbsp;Value<br>Calculator&nbsp;→</span></a>

Cite: Fair Value Calculator (2026). "Taiwan Hopax Chemsistry MFG Co Ltd Fair Value". https://www.fairvalue-calculator.com/stock/6509

Frequently asked questions

Is Taiwan Hopax Chemsistry MFG Co Ltd (6509) overvalued or undervalued?

As of Sep 24, 2026, our model estimates a fair value of 48.86 TWD versus a price of 47.55 TWD, about +3% upside (fairly valued).

What is the fair value of 6509?

Our model-based fair value for Taiwan Hopax Chemsistry MFG Co Ltd is 48.86 TWD (as of Sep 24, 2026), built from audited fundamentals. The current price: 47.55 TWD.

What is the quality score of 6509?

Taiwan Hopax Chemsistry MFG Co Ltd has a Quality Score of 65/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.

What is the price target for Taiwan Hopax Chemsistry MFG Co Ltd (6509)?

Our model-based price target is the fair value of 48.86 TWD (as of Sep 24, 2026) from 25 valuation models. Cautious scenario 36.64 TWD, optimistic scenario 61.07 TWD. It is a calculation from audited fundamentals, not an analyst target.

What is the Taiwan Hopax Chemsistry MFG Co Ltd stock forecast for 2026?

Our models put fair value at 48.86 TWD, about +3% upside versus a price of 47.55 TWD (fairly valued). Cautious scenario 36.64 TWD, optimistic scenario 61.07 TWD. The calculation is refreshed regularly with new filings.

What is the revenue of Taiwan Hopax Chemsistry MFG Co Ltd (6509)?

Taiwan Hopax Chemsistry MFG Co Ltd reported trailing-twelve-month revenue of about 4.9B TWD (latest available figure, as of Sep 24, 2026).

Does Taiwan Hopax Chemsistry MFG Co Ltd pay a dividend?

Taiwan Hopax Chemsistry MFG Co Ltd currently shows a dividend yield of about 2.94% relative to its recent price (as of Sep 24, 2026).

What growth is priced into Taiwan Hopax Chemsistry MFG Co Ltd (6509)?

For today's price to be fair in a discounted-cash-flow model, Taiwan Hopax Chemsistry MFG Co Ltd would have to grow free cash flow by +4.4 % per year for five years (discount rate 11.8 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +6.3 % per year. As of Sep 24, 2026.

What discount rate (WACC) does the fair value of 6509 use?

Our models discount Taiwan Hopax Chemsistry MFG Co Ltd at 11.8 %: a base by market capitalisation (micro), damped by beta 0.45, country premium for Taiwan. The same rate applies in all 26 models.

What is a reverse DCF?

A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Taiwan Hopax Chemsistry MFG Co Ltd that is +4.4 % per year a year over ten years, using the same discount rate (11.8 %) and the same formula as our fair value.

How much growth has Taiwan Hopax Chemsistry MFG Co Ltd (6509) delivered so far?

Over the past 5 years revenue at Taiwan Hopax Chemsistry MFG Co Ltd grew +6.3 % a year. The price currently implies +4.4 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.

How fast is the sector of Taiwan Hopax Chemsistry MFG Co Ltd (6509) growing?

The median revenue growth in the sector is +3.3 % a year. That is the yardstick for the growth priced into Taiwan Hopax Chemsistry MFG Co Ltd (+4.4 % per year a year): it shows whether the expectation is within the usual range or beyond it.

What is the free cash flow yield of Taiwan Hopax Chemsistry MFG Co Ltd (6509)?

The free-cash-flow yield on the price is 8.81 %: that much free cash flow Taiwan Hopax Chemsistry MFG Co Ltd produces per unit of market value. When it exceeds the discount rate of our models (11.8 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.

What is the intrinsic value of Taiwan Hopax Chemsistry MFG Co Ltd (6509)?

Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Taiwan Hopax Chemsistry MFG Co Ltd it is 48.86 TWD per share (as of Sep 24, 2026), against a price of 47.55 TWD. It is the blended result of 25 valuation models (cash flow, earnings, asset, dividend).

Is Taiwan Hopax Chemsistry MFG Co Ltd stock overvalued or undervalued in 2026?

As of Sep 24, 2026, 6509 trades below its calculated fair value: price 47.55 TWD, fair value 48.86 TWD, a gap of about +3% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.

Is fair value the same as the market price of 6509?

No. The price is what the market pays today (47.55 TWD); the fair value is what the company's own numbers justify (48.86 TWD). For Taiwan Hopax Chemsistry MFG Co Ltd the two are 1.31 TWD per share apart. That gap is exactly why we show both numbers side by side.

How much is Taiwan Hopax Chemsistry MFG Co Ltd worth?

The market values Taiwan Hopax Chemsistry MFG Co Ltd at about 9.3B TWD (market capitalisation, as of Sep 24, 2026). Per share that is 47.55 TWD; our models calculate a fair value of 48.86 TWD per share.

What do the bullish and bearish scenarios say about 6509?

Our models span a range for Taiwan Hopax Chemsistry MFG Co Ltd: cautious scenario 36.64 TWD, base 48.86 TWD, optimistic 61.07 TWD per share (as of Sep 24, 2026, price 47.55 TWD). The range comes from different growth and margin assumptions, not from analyst opinions.

What is the P/E ratio of 6509?

Taiwan Hopax Chemsistry MFG Co Ltd trades at a price-to-earnings ratio of 17.4 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 48.86 TWD is built from several models across several years. Other multiples: P/B 1.8, P/S 1.9, EV/EBITDA 6.4.

How solid is the balance sheet of Taiwan Hopax Chemsistry MFG Co Ltd (6509)?

Balance-sheet figures for Taiwan Hopax Chemsistry MFG Co Ltd (as of Sep 24, 2026): return on equity 12.5%, debt of 0.02 per unit of equity. They feed the Quality Score of 65/100, which measures business quality independently of the share price.

How far is 6509 from its 52-week high?

Taiwan Hopax Chemsistry MFG Co Ltd trades at 47.55 TWD, about 17% below its 52-week high of 57.50 TWD and 57% above the low of 30.30 TWD (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of 48.86 TWD is for.

Which stocks are comparable to Taiwan Hopax Chemsistry MFG Co Ltd?

From the same area (Basic Materials) we also value Linde plc, The Sherwin-Williams Company, Ecolab Inc, Air Products and Chemicals, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.

Is Taiwan Hopax Chemsistry MFG Co Ltd stock attractive at the current price?

The data as of Sep 24, 2026: price 47.55 TWD, calculated fair value 48.86 TWD (+3%), Quality Score 65/100, from 25 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.

How is the fair value of 6509 calculated?

We run Taiwan Hopax Chemsistry MFG Co Ltd through 25 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 48.86 TWD, with the spread shown as a cautious and an optimistic scenario.

Is it still worth investing in stocks now?

The global stock market currently sits 13.0 % above its aggregate fair value. Taiwan Hopax Chemsistry MFG Co Ltd currently trades 3 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.

What is the share price of Taiwan Hopax Chemsistry MFG Co Ltd (6509)?

The closing price on Sep 24, 2026 was 47.55 TWD. Our model-based fair value is 48.86 TWD, about +3% upside (fairly valued). We carry closing prices from our data provider, not a live tick.

What should I pay attention to with Taiwan Hopax Chemsistry MFG Co Ltd right now?

The price sits close to our fair value, market and models broadly agree here, little valuation tension. The price sits in the lower half of our model range, the side with the larger margin of safety. The data supports the verdict: every model runs on fully documented inputs.

Where does the earnings growth of Taiwan Hopax Chemsistry MFG Co Ltd (6509) come from?

Earnings per share at Taiwan Hopax Chemsistry MFG Co Ltd grew +19.6 % a year from 2012 to 2023. Broken into its drivers: revenue per share +3.6 %, EBIT margin +13.6 %, tax rate +3.9 %, residual (interest, one-offs) −2.2 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of Taiwan Hopax Chemsistry MFG Co Ltd

How large is the market capitalisation of Taiwan Hopax Chemsistry MFG Co Ltd (6509)?

The market capitalisation of Taiwan Hopax Chemsistry MFG Co Ltd is 9.3B TWD (≈ $294M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.

What is the P/S ratio of Taiwan Hopax Chemsistry MFG Co Ltd (6509)?

The price-to-sales ratio of Taiwan Hopax Chemsistry MFG Co Ltd is 2.03 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.

What are the earnings per share of Taiwan Hopax Chemsistry MFG Co Ltd (6509)?

Earnings per share at Taiwan Hopax Chemsistry MFG Co Ltd are 2.73 TWD (price ÷ EPS = P/E 17.4). Earnings per share over the last twelve months: total profit spread across every single share.

What is the dividend yield of Taiwan Hopax Chemsistry MFG Co Ltd (6509)?

The dividend yield of Taiwan Hopax Chemsistry MFG Co Ltd is 2.9% (payout 51.3%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.

What is the net margin of Taiwan Hopax Chemsistry MFG Co Ltd (6509)?

The net margin of Taiwan Hopax Chemsistry MFG Co Ltd is 11.6% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.

What is the return on equity of Taiwan Hopax Chemsistry MFG Co Ltd (6509)?

The return on equity (ROE) of Taiwan Hopax Chemsistry MFG Co Ltd is 12.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.

What is the EBIT return on assets of Taiwan Hopax Chemsistry MFG Co Ltd (6509)?

On an EBIT basis the return on assets of Taiwan Hopax Chemsistry MFG Co Ltd is 9.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.

What is the operating margin of Taiwan Hopax Chemsistry MFG Co Ltd (6509)?

The operating margin of Taiwan Hopax Chemsistry MFG Co Ltd is 22.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.

How fast is revenue growing at Taiwan Hopax Chemsistry MFG Co Ltd (6509)?

Revenue at Taiwan Hopax Chemsistry MFG Co Ltd is growing +5.3% versus a year earlier (3y avg −3.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.

How fast are earnings growing at Taiwan Hopax Chemsistry MFG Co Ltd (6509)?

Earnings per share at Taiwan Hopax Chemsistry MFG Co Ltd are growing +43.8% versus a year earlier. How much earnings per share grew versus a year earlier.

How much net debt does Taiwan Hopax Chemsistry MFG Co Ltd (6509) carry?

The net debt of Taiwan Hopax Chemsistry MFG Co Ltd is 810M TWD (fiscal year 2023, ≈ 1.0 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.

Free · no account needed

Watch Taiwan Hopax Chemsistry MFG Co Ltd in the live analysis

One click puts Taiwan Hopax Chemsistry MFG Co Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.